INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Form 4 transactions

66,706 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MM
Mulhall Christopher M.VP - Chief Accounting Officer
FTVFortive Corp
Option exercise
M—
3,351 sh
Oct 30, 2026Nov 2, 2026
Page 105 of 1668
← PrevNext →
traded Oct 30, 2026
+3d
SEC Form 4

Evidence

9
AE
Alfonso EduardoDirector
BLCOBausch & Lomb Corp
Grant or award
A$23K
1,125 sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC Form 4

Evidence

9
SP
Schwartz Barry PaulDirector
QMLSQumulusAI, Inc.
Option exercise
M$331
479 sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
10.4K sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
1,753 sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
GJ
Gahan Patrick JosephDirector
QMLSQumulusAI, Inc.
Option exercise
M$34K
11.4K sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
GJ
Gahan Patrick JosephDirector
QMLSQumulusAI, Inc.
Option exercise
M$601
182 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
GJ
Gahan Patrick JosephDirector
QMLSQumulusAI, Inc.
Option exercise
M—
11.4K sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
GJ
Gahan Patrick JosephDirector
QMLSQumulusAI, Inc.
Option exercise
M—
182 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
TC
Tarvin Landon CPresident, UFP Retail
UFPIUFP INDUSTRIES INC
Grant or award
A$1,147
14 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
RA
Rhymes Michael AnthonyDirector
SHENSHENANDOAH TELECOMMUNICATIONS CO/VA/
Grant or award
A$500
49 sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
JW
Jeggle Helmut WolfgangDirector, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
160.9K sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
RC
Robertson Russel CDirector
BLCOBausch & Lomb Corp
Grant or award
A$26K
1,256 sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC Form 4

Evidence

9
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Grant or award
A—
70.0K sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
QL
Quaglio Kenneth LDirector
SHENSHENANDOAH TELECOMMUNICATIONS CO/VA/
Grant or award
A$1,000
98 sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
147.2K sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Grant or award
A—
379.1K sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC Form 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Grant or award
A—
758.2K sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC Form 4

Evidence

9
EM
Ellerbrook Michael MPresident, UFP Construction
UFPIUFP INDUSTRIES INC
Grant or award
A$1,393
17 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
156 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
EL
Evans Terry LChief Commercial Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
WG
Woodruff Ronald GreerEVP Safety, ESG, Maintenance
JBHTHUNT J B TRANSPORT SERVICES INC
Option exercise
M—
230 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
VH
van Houte HansChief Financial Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,859 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
BJ
Boattini JenniferSR VP Legal/General Counsel
JBHTHUNT J B TRANSPORT SERVICES INC
Tax withholding
F$40K
180 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
BJ
Boattini JenniferSR VP Legal/General Counsel
JBHTHUNT J B TRANSPORT SERVICES INC
Option exercise
M—
528 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
BJ
Boattini JenniferSR VP Legal/General Counsel
JBHTHUNT J B TRANSPORT SERVICES INC
Tax withholding
F$43K
196 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
GP
Guerre Robert PaulCorp. Sec, Dir Corp Compliance
UFPIUFP INDUSTRIES INC
Grant or award
A$1,393
17 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
BJ
Boattini JenniferSR VP Legal/General Counsel
JBHTHUNT J B TRANSPORT SERVICES INC
Option exercise
M—
474 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
HE
Hunton Stephen EricChief Marketing Officer
QMLSQumulusAI, Inc.
Option exercise
M$2,069
2,998 sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC Form 4

Evidence

9
GJ
Gahan Patrick JosephDirector
QMLSQumulusAI, Inc.
Option exercise
M—
24.4K sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
KC
Krosnowski Scott CarrollChief Financial Officer
QMLSQumulusAI, Inc.
Option exercise
M—
50.7K sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
MM
Mulhall Christopher M.VP - Chief Accounting Officer
FTVFortive Corp
Option exercise
M$39K
1,017 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
SG
Salvia Investment GmbH10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
1.47M sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
4,155 sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
DJ
DiCiollo Anthony JHead of Institutional Segment
SNEXStoneX Group Inc.
Grant or award
A—
6,604 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
KC
Krosnowski Scott CarrollChief Financial Officer
QMLSQumulusAI, Inc.
Option exercise
M—
4,740 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
RP
Reed John PDirector, CEO and Chairman, 10% Owner
ARHSArhaus, Inc.
Derivative conversion
C—
222.2K sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC Form 4

Evidence

9
JW
Jeggle Helmut WolfgangDirector, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
3.14M sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
JW
Jeggle Helmut WolfgangDirector, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
1.47M sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
BD
Brown Kevin D.Director
HAYWHayward Holdings, Inc.
Grant or award
A—
1,446 sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
  3. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K